168 related articles for article (PubMed ID: 6355533)
1. Verapamil prophylaxis of migraine. A double-blind, placebo-controlled study.
Solomon GD; Steel JG; Spaccavento LJ
JAMA; 1983 Nov; 250(18):2500-2. PubMed ID: 6355533
[TBL] [Abstract][Full Text] [Related]
2. Verapamil in migraine prophylaxis--a five-year review.
Solomon GD
Headache; 1989 Jul; 29(7):425-7. PubMed ID: 2668225
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double-blind randomized cross-over study].
Paterna S; Martino SG; Campisi D; Cascio Ingurgio N; Marsala BA
Clin Ter; 1990 Jul; 134(2):119-25. PubMed ID: 2147612
[TBL] [Abstract][Full Text] [Related]
4. Verapamil in prophylactic therapy of migraine.
Markley HG; Cheronis JC; Piepho RW
Neurology; 1984 Jul; 34(7):973-6. PubMed ID: 6539877
[TBL] [Abstract][Full Text] [Related]
5. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
7. A double-blind placebo-controlled trial of indobufen in the prophylaxis of migraine.
Carrieri PB; Orefice G; Sorge F
Acta Neurol Scand; 1988 Jun; 77(6):433-6. PubMed ID: 3043994
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study.
Lewis D; Paradiso E
Headache; 2007; 47(10):1409-17. PubMed ID: 18052950
[TBL] [Abstract][Full Text] [Related]
9. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
[TBL] [Abstract][Full Text] [Related]
10. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial.
Tfelt-Hansen P; Standnes B; Kangasneimi P; Hakkarainen H; Olesen J
Acta Neurol Scand; 1984 Jan; 69(1):1-8. PubMed ID: 6367336
[TBL] [Abstract][Full Text] [Related]
11. Nifedipine in the prophylaxis of classic migraine: a crossover, double-masked, placebo-controlled study of headache frequency and side effects.
McArthur JC; Marek K; Pestronk A; McArthur J; Peroutka SJ
Neurology; 1989 Feb; 39(2 Pt 1):284-6. PubMed ID: 2644581
[TBL] [Abstract][Full Text] [Related]
12. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.
Newman L; Mannix LK; Landy S; Silberstein S; Lipton RB; Putnam DG; Watson C; Jöbsis M; Batenhorst A; O'Quinn S
Headache; 2001 Mar; 41(3):248-56. PubMed ID: 11264684
[TBL] [Abstract][Full Text] [Related]
13. The impact of migraine on daily activities: effect of topiramate compared with placebo.
Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
[TBL] [Abstract][Full Text] [Related]
14. Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo.
Zeeberg I; Orholm M; Nielsen JD; Honore PL; Larsen JJ
Acta Neurol Scand; 1981 Dec; 64(6):452-9. PubMed ID: 6753446
[TBL] [Abstract][Full Text] [Related]
15. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.
Dodick DW; Goadsby PJ; Spierings EL; Scherer JC; Sweeney SP; Grayzel DS
Lancet Neurol; 2014 Sep; 13(9):885-92. PubMed ID: 25127173
[TBL] [Abstract][Full Text] [Related]
17. Migraine prophylactic drugs: proof of efficacy, utilization and cost.
Ramadan NM; Schultz LL; Gilkey SJ
Cephalalgia; 1997 Apr; 17(2):73-80. PubMed ID: 9137841
[TBL] [Abstract][Full Text] [Related]
18. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial.
Lakshmi CV; Singhi P; Malhi P; Ray M
J Child Neurol; 2007 Jul; 22(7):829-35. PubMed ID: 17715274
[TBL] [Abstract][Full Text] [Related]
19. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
